FDA Dietary Supplement AER Detection, Analysis Need Refining – ASCPT
This article was originally published in The Tan Sheet
Executive Summary
The American Society for Clinical Pharmacology & Therapeutics is calling for legislation and funding that would enable FDA to improve the detection and assessment of adverse events associated with dietary supplement use
You may also be interested in...
“Passive” Botanicals Surveillance Should Mimic Drug AER System – ER Doc
Plant-derived supplements should be monitored under an active surveillance system similar to drugs, according to botanist and emergency-room physician Mary Palmer, MD, George Washington Medical Center
“Passive” Botanicals Surveillance Should Mimic Drug AER System – ER Doc
Plant-derived supplements should be monitored under an active surveillance system similar to drugs, according to botanist and emergency-room physician Mary Palmer, MD, George Washington Medical Center
“Passive” Botanicals Surveillance Should Mimic Drug AER System – ER Doc
Plant-derived supplements should be monitored under an active surveillance system similar to drugs, according to botanist and emergency-room physician Mary Palmer, MD, George Washington Medical Center